Global Preclinical Imaging Market Set to Reach USD 5.101 Million by 2029 | MarketsandMarkets™ [Yahoo! Finance]
Bruker Corporation (BRKR)
Last bruker corporation earnings: 10/31 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.bruker.com/investors/default.aspx
Company Research
Source: Yahoo! Finance
Delray Beach, FL, Oct. 03, 2025 (GLOBE NEWSWIRE) -- The global preclinical imaging market , valued at US$3.807 million in 2023, stood at US$3.997 million in 2024 and is projected to advance at a resilient CAGR of 5.0% from 2024 to 2029, culminating in a forecasted valuation of US$5.101 million by the end of the period. This growth reflects mounting demand for advanced, cost-effective imaging systems that support pharmaceutical innovation, drug discovery, and academic research. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=841 Market Drivers: Why Demand Is Rising Preclinical imaging plays a pivotal role in visualizing disease processes and evaluating new therapies in animal models before human trials. A key driver is the increasing adoption of non-invasive small-animal imaging techniques, which reduce the need for animal euthanasia, support longitudinal studies, and align with the global 3Rs principle (Replacement, Reduction, Refinement). These m
Show less
Read more
Impact Snapshot
Event Time:
BRKR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BRKR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BRKR alerts
High impacting Bruker Corporation news events
Weekly update
A roundup of the hottest topics
BRKR
News
- Indaba Capital Announces Sale of AST Revolution to BrukerBusiness Wire
- Bruker (NASDAQ:BRKR) was upgraded by analysts at Rothschild Redb to a "strong-buy" rating.MarketBeat
- Bruker (NASDAQ:BRKR) was given a new $60.00 price target on by analysts at Redburn Partners.MarketBeat
- Bruker (NASDAQ:BRKR) is now covered by analysts at Rothschild & Co Redburn. They set a "buy" rating and a $60.00 price target on the stock.MarketBeat
- Spatial Biology Market Analysis and Forecast, 2025-2035: Stellaromics, RareCyte, and 10x Genomics Drive Innovation and Funding Momentum [Yahoo! Finance]Yahoo! Finance
BRKR
Earnings
- 11/3/25 - Beat
BRKR
Sec Filings
- 12/2/25 - Form 4
- 12/1/25 - Form 144
- 11/14/25 - Form SCHEDULE
- BRKR's page on the SEC website